BackBristol-Myers Squibb Overview

Bristol-Myers Squibb Intangible Assets

Track Bristol-Myers Squibb's intangible assets ($17B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$17.39B

Peer average

Loading

Bristol-Myers Squibb Intangible Assets History

Loading

Bristol-Myers Squibb vs. peers: Intangible Assets Comparison

Loading

Bristol-Myers Squibb Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bristol-Myers Squibb (BMY) FAQ

The latest intangible assets for BMY is $17B as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Bristol-Myers Squibb's historical trend and sector peers before judging valuation or financial health.

Over the past year, BMY's intangible assets moved from $0 to $17B. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bristol-Myers Squibb's operating scale or balance-sheet position.

A intangible assets figure of $17B for BMY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BMY's intangible assets ($17B), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bristol-Myers Squibb's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.